PlainRecalls
FDA Drug Moderate Class II Ongoing

HydrALAZINE Hydrochloride, 100 Tablets (10x10), USP, 50mg, Rx only, Manufactured by Strides Pharma Science Ltd, Bengaluru, India, Distributed by McKesson by: McKesson Corporation dba SKY Packaging, TN 38141. NDC 63739-328-10

Reported: February 12, 2025 Initiated: January 24, 2025 #D-0220-2025

Product Description

HydrALAZINE Hydrochloride, 100 Tablets (10x10), USP, 50mg, Rx only, Manufactured by Strides Pharma Science Ltd, Bengaluru, India, Distributed by McKesson by: McKesson Corporation dba SKY Packaging, TN 38141. NDC 63739-328-10

Reason for Recall

Failed Impurities/Degradation Specifications

Details

Recalling Firm
SKY PACKAGING
Distribution
Nationwide within the United States
Location
Memphis, TN

Frequently Asked Questions

What product was recalled?
HydrALAZINE Hydrochloride, 100 Tablets (10x10), USP, 50mg, Rx only, Manufactured by Strides Pharma Science Ltd, Bengaluru, India, Distributed by McKesson by: McKesson Corporation dba SKY Packaging, TN 38141. NDC 63739-328-10. Recalled by SKY PACKAGING.
Why was this product recalled?
Failed Impurities/Degradation Specifications
Which agency issued this recall?
This recall was issued by the FDA Drug on February 12, 2025. Severity: Moderate. Recall number: D-0220-2025.